Log In
Print
BCIQ
Print
Print this Print this
 

AVN-211

  Manage Alerts
Collapse Summary General Information
Company Avineuro Pharmaceuticals Inc.
DescriptionSmall molecule serotonin (5-HT6) receptor antagonist
Molecular Target Serotonin (5-HT6) receptor
Mechanism of ActionSerotonin (5-HT6) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation

Partner

AllaChem LLC


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today